Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women (IOPForteo)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Elizabeth Shane, Columbia University
ClinicalTrials.gov Identifier:
NCT00697463
First received: June 11, 2008
Last updated: February 1, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)